Cytosorbents Clears Nasdaq Bid Price Hurdle, but MVLS Deficiency Lingers
CTSO is trading near its 52-week low of $5.13 (3.7% above the low).
Summary
Cytosorbents regained compliance with Nasdaq's minimum bid price rule after its reverse split, but remains non-compliant with the $35 million market value requirement and faces a December 28, 2026 deadline to fix it.
Key Events · Legal and Risk Events · CTSO
-
Minimum Bid Price Compliance Regained
Nasdaq confirmed on September 22, 2026 that Cytosorbents has regained compliance with the $1.00 minimum bid price requirement after 10 consecutive trading sessions above $1.00, closing that matter.
-
MVLS Deficiency Still Open
The company remains non-compliant with the $35 million market value of listed securities (MVLS) requirement and has until December 28, 2026 to regain compliance or face delisting.
-
Potential Equity Increase
Cytosorbents is evaluating options to regain MVLS compliance, including increasing stockholders' equity to at least $2.5 million, though no specific plan has been announced.
-
Reverse Split Enabled Compliance
The 1-for-20 reverse split effective September 8, 2026 reduced outstanding shares from 63.0 million to approximately 3.15 million, lifting the stock price above the $1.00 threshold.
Analysis · CTSO · Industrial Applications And Services
One Nasdaq listing hurdle is now behind Cytosorbents: the minimum bid price requirement, satisfied after the 1-for-20 reverse split kept the stock above $1.00 for 10 consecutive sessions. Still unresolved is the $35 million market value of listed securities (MVLS) rule, with a December 28, 2026 deadline to regain compliance. Given a market cap of roughly $16.8 million, the company would need to more than double its market value or raise stockholders' equity to at least $2.5 million to avoid delisting. The going-concern warning and $4.4 million in unrestricted cash from the Q2 10-Q make this a live risk.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 31.7% of the 1731 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTSO was trading at $5.32 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.8M. The 52-week trading range was $5.13 to $20.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.